KARLA CERVANTES: Open Payments
NPI 1386206977 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 66 payments from 12 companies in 2025. Trend: 2023 $72 · 2024 $1,283 · 2025 $1,354
Food & beverage: $1,270Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $357 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $281 |
| Janssen Biotech, Inc. | 13 | $228 |
| QOL Medical, LLC | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 5 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| PFIZER INC. | 3 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Ardelyx, Inc. | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $28 |
Products named: TREMFYA, RINVOQ, ENTYVIO, Sucraid, GATTEX, DUPIXENT, CREON, SKYRIZI.
Industry payments across TX — which companies pay providers there.
